Research library
Sources, with the status on the record.
Each row is a paper or a ClinicalTrials.gov entry checked on 21 November 2026. Titles are the authors’ or the registry’s words. Nalen Lab does not restate them as claims about these products. A registration is not a result.
Records checked 2026-11-21. Open registry rows in this view: 1. Selank has published papers and no verified intervention trial.
Loading filters…
Epitalon
2003
Publication
Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells.
Khavinson VKh et al. · Bulletin of Experimental Biology and Medicine
PublishedSame compound as the catalogue listing
Cell-culture paper. Epithalon is the spelling used on the record. The title is the authors' wording.
View in the catalogueEpitalon
2006
Publication
Effect of the synthetic pineal peptide epitalon on spontaneous carcinogenesis in female C3H/He mice.
Kossoy G et al. · In Vivo
PublishedSame compound as the catalogue listing
Mouse study.
View in the catalogueEpitalon
2025
Publication
Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties.
Araj SK et al. · International Journal of Molecular Sciences
PublishedSame compound as the catalogue listing
Review. The title is the authors' wording.
View in the catalogueEpitalon
2026
Registry
Systemic and Topical Geroprotective Rejuvenation Assessed by START/REST Aging Clocks
Early phase 1 · ClinicalTrials.gov · NCT07888595 · Frontiers in Bioscience Research Institute and Aging
Enrolling by invitationMeasures or combines the compound; not a single-compound vial study
Same record as the GHK-Cu row. The topical serum is described as containing Epitalon among other peptides, plus other agents. Not an Epitalon-only trial.
View in the catalogue